Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
5 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//PSYCHOLOGY, EXPERIMENTAL | 1830502 |
487 | 3 | MYASTHENIA GRAVIS//THYMOMA//THYMIC CARCINOMA | 24025 |
516 | 2 | MYASTHENIA GRAVIS//ACETYLCHOLINE RECEPTOR//AGRIN | 15575 |
19893 | 1 | DALFAMPRIDINE//FAMPRIDINE//4 AMINOPYRIDINE | 507 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | DALFAMPRIDINE | authKW | 1353743 | 6% | 78% | 28 |
2 | FAMPRIDINE | authKW | 1112285 | 6% | 62% | 29 |
3 | 4 AMINOPYRIDINE | authKW | 942972 | 19% | 15% | 98 |
4 | FAMPRIDINE SR | authKW | 442041 | 2% | 89% | 8 |
5 | AMPYRA | authKW | 248649 | 1% | 100% | 4 |
6 | 4 AMINOPYRIDINE DERIVATIVES | authKW | 124325 | 0% | 100% | 2 |
7 | IMMEDIATE RELEASE FAMPRIDINE | authKW | 124325 | 0% | 100% | 2 |
8 | 3 HYDROXY 4 AMINOPYRIDINE | authKW | 62162 | 0% | 100% | 1 |
9 | 3 HYDROXY 4 AMINOPYRIDINE SULFATE | authKW | 62162 | 0% | 100% | 1 |
10 | 4 AMINIPYRIDINE | authKW | 62162 | 0% | 100% | 1 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 2089 | 38% | 0% | 193 |
2 | Neurosciences | 1020 | 27% | 0% | 139 |
3 | Clinical Neurology | 896 | 19% | 0% | 98 |
4 | Physiology | 176 | 7% | 0% | 37 |
5 | Rehabilitation | 77 | 3% | 0% | 15 |
6 | Anesthesiology | 69 | 3% | 0% | 13 |
7 | Toxicology | 32 | 3% | 0% | 16 |
8 | Critical Care Medicine | 27 | 2% | 0% | 9 |
9 | Medicine, Research & Experimental | 10 | 3% | 0% | 15 |
10 | Chemistry, Multidisciplinary | 8 | 6% | 0% | 30 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | DPT EMERGENCY MED | 62162 | 0% | 100% | 1 |
2 | LOUIST STOKES CLEVELAND | 62162 | 0% | 100% | 1 |
3 | NEUROLCHIEF NEUROIMMUNOL UNIT | 62162 | 0% | 100% | 1 |
4 | OBSTET GYNAECOL HAARTMANINKATU 2 | 62162 | 0% | 100% | 1 |
5 | PHARMACOL EXTERNAL SECT | 62162 | 0% | 100% | 1 |
6 | PHARMACOL MED GENET | 62162 | 0% | 100% | 1 |
7 | STANFORD MULTIPLE SCLEROSIS | 62162 | 0% | 100% | 1 |
8 | SUMMER FELLOWSHIP PROGRAM | 62162 | 0% | 100% | 1 |
9 | WALES CLIN | 62162 | 0% | 100% | 1 |
10 | PULM SECT 111JW | 62160 | 0% | 50% | 2 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE | 3315 | 2% | 0% | 11 |
2 | GENERAL PHARMACOLOGY | 1860 | 1% | 1% | 5 |
3 | EUROPEAN JOURNAL OF PHARMACOLOGY | 1812 | 6% | 0% | 29 |
4 | THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS | 1409 | 0% | 1% | 2 |
5 | JOURNAL OF NATURAL TOXINS | 1050 | 0% | 1% | 2 |
6 | JOURNAL OF NEUROTRAUMA | 806 | 1% | 0% | 7 |
7 | PHARMACEUTICA ACTA HELVETIAE | 799 | 1% | 0% | 3 |
8 | NEUROPHARMACOLOGY | 766 | 2% | 0% | 11 |
9 | JAPANESE JOURNAL OF PHYSIOLOGY | 741 | 1% | 0% | 5 |
10 | SPINAL CORD | 739 | 1% | 0% | 6 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |